Tetrandrine upregulates HTR1D to attenuate mesangial cell pathological injury in IgA nephropathy: A bioinformatics and machine learning-based study
Letters in Drug Design & Discovery · 2026-11 · 100672
DOI: 10.1016/j.lddd.2026.100672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-11. Verfasst von Li-hua Luo und 7 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Luo, L., Liu, D., Tan, F., Guo, Z., Peng, J., Wu, Y., Zhang, X., & Wei, Z. (2026). Tetrandrine upregulates HTR1D to attenuate mesangial cell pathological injury in IgA nephropathy: A bioinformatics and machine learning-based study. Letters in Drug Design & Discovery, 100672. https://doi.org/10.1016/j.lddd.2026.100672
Vancouver
Luo L, Liu D, Tan F, Guo Z, Peng J, Wu Y, et al. Tetrandrine upregulates HTR1D to attenuate mesangial cell pathological injury in IgA nephropathy: A bioinformatics and machine learning-based study. Letters in Drug Design & Discovery. 2026:100672. doi:10.1016/j.lddd.2026.100672
BibTeX
@article{Luo2026,
author = {Luo, Li-hua and Liu, Dehui and Tan, Fei and Guo, Zhiwei and Peng, Juan and Wu, Yicai and Zhang, Xuebing and Wei, Zi-Jie},
title = {Tetrandrine upregulates HTR1D to attenuate mesangial cell pathological injury in IgA nephropathy: A bioinformatics and machine learning-based study},
journal = {Letters in Drug Design & Discovery},
year = {2026},
pages = {100672},
doi = {10.1016/j.lddd.2026.100672}
}
EUVIMED